This prospective cohort study examined survival after surgical treatment of skeletal metastases in 241 patients. It asked which clinical features predict 1-year survival and whether spinal and extremity metastases differ in prognosis. The result was a five-criterion scoring model that stratifies patients into groups with 1-year survival ranging from 50% to 0%.
Before this paper, decisions about extent of surgery for skeletal metastases were largely intuitive — there was no validated framework to distinguish patients who might live long enough to justify aggressive reconstruction from those who would not.
The Bauer score gives you five binary criteria to apply in clinic: no visceral metastases, no pathologic fracture, solitary skeletal lesion, primary tumor not lung, and primary tumor is breast/kidney/myeloma/lymphoma. Count how many apply.
When a patient scores 4-5, plan for wide resection and durable reconstruction. They have a 50% chance of living a year. When they score 0-1, all patients died within 6 months; focus on the least morbid stabilization, not oncologic margins.
This is also why age alone should never exclude a patient from surgery. The paper explicitly shows age has no survival impact. Primary tumor type and metastatic burden are what matter.
This prospective cohort study examined survival after surgical treatment of skeletal metastases in 241 patients. It asked which clinical features predict 1-year survival and whether spinal and extremity metastases differ in prognosis. The result was a five-criterion scoring model that stratifies patients into groups with 1-year survival ranging from 50% to 0%.
Before this paper, decisions about extent of surgery for skeletal metastases were largely intuitive — there was no validated framework to distinguish patients who might live long enough to justify aggressive reconstruction from those who would not.
The Bauer score gives you five binary criteria to apply in clinic: no visceral metastases, no pathologic fracture, solitary skeletal lesion, primary tumor not lung, and primary tumor is breast/kidney/myeloma/lymphoma. Count how many apply.
When a patient scores 4-5, plan for wide resection and durable reconstruction. They have a 50% chance of living a year. When they score 0-1, all patients died within 6 months; focus on the least morbid stabilization, not oncologic margins.
This is also why age alone should never exclude a patient from surgery. The paper explicitly shows age has no survival impact. Primary tumor type and metastatic burden are what matter.